Table 2.

Odds Ratios of Insulin Pump Treatment in Pediatric Patients with Type 1 Diabetes, 0–19 Years Old, for Treatment Year 2009, Categorized as Patients of Turkish Origin and Those Without Migration Background

	Prevalence odds ratios
	Model 1	Model 2	Model 3	Model 4	Model 5 (full model)
Migration background (no vs. Turkish)	0.50 (0.42–0.58)	0.49 (0.42–0.57)	0.47 (0.40–0.55)	0.53 (0.44–0.62)	0.51 (0.43–0.60)
Sex (male vs. female)	0.80 (0.75–0.85)	1.06 (1.02–1.10)	0.80 (0.75–0.85)	0.80 (0.75–0.86)	0.81 (0.76–0.87)
Age in 2009 (per year increase)	0.88 (0.87–0.89)	0.88 (0.87–0.89)	0.89 (0.88–0.89)	0.92 (0.91–0.93)	0.93 (0.92–0.93)
Diabetes duration (per year increase)	1.17 (1.16–1.18)	1.17 (1.16–1.18)	1.17 (1.16–1.18)	1.17 (1.16–1.18)	1.17 (1.16–1.19)
BMI-SDS (per 1 BMI-SDS increase)		0.80 (0.75–0.85)			1.07 (1.03–1.12)
Number of outpatient visits (per 1 visit increase)			1.12 (1.10–1.14)		1.08 (1.06–1.10)
Number of daily blood glucose measurements (per 1 unit increase)				1.24 (1.21–1.26)	1.30 (1.22–1.27)

Glycated hemoglobin and socioeconomic status variables were not significantly associated when added to Model 1. BMI-SDS, body mass index SD score.